4 results
hematology algorithm treatment discontinue doac duration herdoo2 im length longterm malignancy oncology thromboembolism
HERDOO2 score to identify women with unprovoked venous thrombosis (VTE) at low risk of recurrent venous
from Kahn et al #Management ... #IM #PrimaryCare ... #HERDOO2 #DVT # ... VTE #Anticoagulation ... #Discontinue #BMJ
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis. Currently, edoxaban and rivaroxaban are the only
DVT = deep vein ... weight heparin; BMI ... = venous thromboembolism ... #Anticoagulation ... #Management #Hematology
►
 Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease • Superficial Venous Thrombosis • Upper
of Therapy for Venous ... Thrombophilia • Cancer ... DeLoughery @Bloodman #VTE ... #anticoagulation ... #duration #management
Longterm Venous Thromboembolism Treatment Algorithm Treat for 3 months and reassess • Isolated distal DVT (without cancer)
Longterm Venous ... Isolated distal DVT ... therapy - Second VTE ... Treatment #Algorithm #management ... #hematology #anticoagulation
No results found for "Nystagmus management guidelines primarycare bmj anticoagulation cancer dvt vte venous"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Nystagmus #management #guidelines #primarycare #bmj #anticoagulation #cancer #dvt #vte #venous